Oaktree Acquisition Corp.... (OACC)
NasdaqGM: OACC
· Real-Time Price · USD
10.76
+0.02 (0.19%)
At close: Aug 12, 2026, 11:58 AM
Oaktree Acquisition Corp. III Life Sciences (OACC) Stock Price, Analysis & Data
0.19% (1D)
| Bid | 10.69 |
| Market Cap | 264.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 7.02M |
| Beta | n/a |
| EPS (ttm) | 0.29 |
| PE Ratio (ttm) | 37.1 |
| Forward PE | n/a |
| P/B (ttm) | -36.60 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 10.64 |
| Volume | 141 |
| Avg. Volume (20D) | 19,977 |
| Open | 10.76 |
| Previous Close | 10.74 |
| Day's Range | 10.76 - 10.76 |
| 52-Week Range | 10.30 - 10.88 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About OACC
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded i...
Industry Shell Companies
Sector Financial Services
IPO Date Dec 16, 2024
Employees n/a
Stock Exchange NasdaqGM
Ticker Symbol OACC
Financial Performance
In 2025, Oaktree Acquisition III Life Sciences's revenue was 0, an increase of undefined% compared to the previous year's n/a. Earnings were 7.29M, an increase of undefined%.
Financial Statements